MicroRNA‐200c/429 mediated regulation of Zeb1 augments N‐Cadherin in mouse cardiac mesenchymal cells

Cardiac mesenchymal cells (CMCs) are a promising cell type that showed therapeutic potential in heart failure models. The analysis of the underlying mechanisms by which the CMCs improve cardiac function is on track. This study aimed to investigate the expression of N‐Cadherin, a transmembrane protein that enhances cell adhesion, and recently gained attention for differentiation and augmentation of stem cell function. The mouse CMCs were isolated and analyzed for the mesenchymal markers using flow cytometry. Quantitative real‐time polymerase chain reaction (qRT‐PCR) and western blot analysis were used to assess the expression of N‐Cadherin along with its counteracting molecule E‐Cadherin and their regulator Zeb1 in CMCs and dermal fibroblast. The expression level of miR‐200c and miR‐429 was analyzed using miRNA assays. Transient transfection of miR‐200c followed by qRT‐PCR, western blot analysis, and immunostaining was done in CMCs to analyze the expression of Zeb1, N‐Cadherin, and E‐Cadherin. Flow cytometry analysis showed that CMCs possess mesenchymal markers and absence for hematopoietic and immune cell markers. Increased expression of N‐Cadherin and Zeb1 in CMCs was observed in CMCs at both RNA and protein levels compared to fibroblast. We found significant downregulation of miR‐200c and miR‐429 in CMCs. The ectopic expression of miR‐200c in CMCs significantly downregulated Zeb1 and N‐Cadherin expression. Our findings suggest that the significant downregulation of miR‐200c/429 in CMCs maintains the expression of N‐Cadherin, which may be important for its functional integrity.